Skye Bioscience, Inc. Common Stock (SKYE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.83M
Last updated: Nov 17, 2026 at 4:10 PM ET
Skye Bioscience, Inc. Common Stock (SKYE) Stock Chart
Skye Bioscience, Inc. Common Stock (SKYE) has a latest price of $1.00 on Nov 17, 2026, 55.6% below its 52-week high of $2.25. Its price fell 90.4% over the past 12 months. The month-end price fell 99.9% over the 10 years through Oct 2026, a compound annual decline of 49.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $1,380.00 in Mar 2019 and its lowest $1.28 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SKYE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SKYE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 59.1%, and over 6 months it fell 82.8%. The month-end price fell 90.9% over the 3 years through Oct 2026, a compound annual decline of 55.0%.
| Period | Change |
|---|---|
| 1 month | -34.6% |
| 3 months | -59.1% |
| 6 months | -82.8% |
| 12 months | -90.4% |
| 12 months, with dividends | -90.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -90.9% | -55.0% |
| 5 years | -99.1% | -61.1% |
| 10 years | -99.9% | -49.9% |
Price by Year
Its best calendar year was 2018, when the price rose 163.2%, and its weakest was 2025, when it fell 73.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.28 | -78.7% |
| 2025 | $6.00 | -73.5% |
| 2024 | $22.64 | +4.0% |
| 2023 | $21.76 | -32.8% |
| 2022 | $32.40 | -68.8% |
| 2021 | $104.00 | +30.0% |
| 2020 | $80.00 | -69.5% |
| 2019 | $262.00 | -67.3% |
| 2018 | $800.00 | +163.2% |
| 2017 | $304.00 | -49.7% |
Trading Range
The price is 34.1% below its 50-day average of $1.52 and 77.5% below its 200-day average of $4.44.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.00 | |
| 52-week high | $2.25 | -55.6% |
| 52-week low | $0.26 | +292.2% |
| 50-day average | $1.52 | -34.1% |
| 200-day average | $4.44 | -77.5% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.61 |
| Largest fall, 1 year | -93.8% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SKYE
What is SKYE's 1-year price change?
Skye Bioscience, Inc. Common Stock's price fell 90.4% over the past 12 months. With dividends included, the 12-month total return was -90.4%.
What is SKYE's 5-year price change?
Skye Bioscience, Inc. Common Stock's month-end price fell 99.1% over the 5 years through Oct 2026, a compound annual decline of 61.1%. These figures leave out dividends.
What is SKYE's 52-week high and low?
Skye Bioscience, Inc. Common Stock's 52-week high is $2.25 and its 52-week low is $0.26. Its latest price of $1.00 on Nov 17, 2026 is 55.6% below the high.
What is SKYE's beta?
Skye Bioscience, Inc. Common Stock's 1-year beta against the S&P 500 is 0.61, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 93.8%.
Is the SKYE chart free?
Yes. Advanced Charting for SKYE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SKYE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors